Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > CLLS Cellectis > Detailed Quotes

CLLS Cellectis

2.380
-0.030-1.24%
Close 10/05 16:00 ET
2.3800.0000.00%
Post Mkt Price 10/05 16:02 ET
High
2.490
Open
2.320
Turnover
167.30K
Low
2.235
Pre Close
2.410
Volume
71.73K
Market Cap
108.32M
P/E(TTM)
Loss
52wk High
13.080
Shares
45.51M
P/E(Static)
Loss
52wk Low
2.150
Float Cap
69.79M
Bid/Ask %
0.00%
Historical High
50.000
Shs Float
29.32M
Volume Ratio
0.56
Historical Low
2.150
Dividend TTM
--
Div Yield TTM
--
P/B
0.64
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.25%
Amplitude
10.58%
Avg Price
2.332
Lot Size
1
Float Cap
69.79M
Bid/Ask %
0.00%
Historical High
50.000
Shs Float
29.32M
Volume Ratio
0.56
Historical Low
2.150
Dividend TTM
--
P/B
0.64
Dividend LFY
--
Turnover Ratio
0.25%
Amplitude
10.58%
Avg Price
2.332
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Cellectis SA operates as a clinical stage biotechnological company. The firm operates through the segments: Therapeutics and Plants. The Therapeutics segment focuses on the development of products in the field of immuno-oncology and monogenic diseases. The Plants segment focuses on using Calyxt's proprietary PlantSpringTM technology platform to engineer plant metabolism to produce innovative, high-value, and sustainable materials and products for use in helping customers meet their sustainability targets and financial goals. The company was founded by David J. Sourdive and André Choulika on February 20, 1999 and is headquartered in Paris, France.
CEO: Dr. Andre Choulika
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...